Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “a Randomized Double-blind Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Testing effectiveness (Phase 2)Study completedNCT00827918
What this trial is testing

Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 216
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Testing effectiveness (Phase 2)Study completedNCT00656890
What this trial is testing

MDX-1100 in Subjects With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 110
Testing effectiveness (Phase 2)UnknownNCT06450990
What this trial is testing

Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection

Who this might be right for
Bacterial VaginosisVulvovaginal Candidiasis
NEXBIOME THERAPEUTICS 165
Early research (Phase 1)Not Yet RecruitingNCT07634510
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205

Who this might be right for
Dyslipidemias
Shanghai Minwei Biotechnology Co., Ltd 37
Not applicableStudy completedNCT07839910
What this trial is testing

Wearable tDCS and Acute Golf Shot Performance

Who this might be right for
tDCSGolf Specific PerformanceAthletic Performance Enhancement+1 more
Shanghai University of Sport 67
Testing effectiveness (Phase 2)Study completedNCT06732960
What this trial is testing

The Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients

Who this might be right for
Overweight or Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 50
Not applicableStudy completedNCT05829382
What this trial is testing

Biological Effects of a Polyphenol Supplement

Who this might be right for
Healthy Aging
Helse Stavanger HF 30
Early research (Phase 1)Study completedNCT02222324
What this trial is testing

Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

Who this might be right for
Healthy Subjects
Eisai Inc. 60
Not applicableNot Yet RecruitingNCT07434024
What this trial is testing

Erector Spinae Plane Block for Acute Low Back Pain

Who this might be right for
Non-specific Low Back Pain (NSLBP)
University Hospital, Montpellier 300
Testing effectiveness (Phase 2)Looking for participantsNCT07671924
What this trial is testing

The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)

Who this might be right for
Refractory Chronic Cough
Trevi Therapeutics 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06847724
What this trial is testing

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Sandoz 183
Large-scale testing (Phase 3)Study completedNCT01850524
What this trial is testing

IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 705
Early research (Phase 1)Study completedNCT05226923
What this trial is testing

Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects

Who this might be right for
Bacterial Infections
Sumitovant Biopharma, Inc. 123
Testing effectiveness (Phase 2)Study completedNCT00297180
What this trial is testing

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

Who this might be right for
Obesity
GlaxoSmithKline 136
Large-scale testing (Phase 3)Study completedNCT03726879
What this trial is testing

Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 454
Not applicableStudy completedNCT05848596
What this trial is testing

Handwashing Knowledge and Practice of Palliative Care

Who this might be right for
Hand Hygiene
Istanbul Sultanbeyli State Hospital 60
Large-scale testing (Phase 3)Study completedNCT04218162
What this trial is testing

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean

Who this might be right for
Acute Migraine
IlDong Pharmaceutical Co Ltd 294
Post-approval studies (Phase 4)Study completedNCT00953979
What this trial is testing

Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

Who this might be right for
Ankylosing SpondylitisTreatment
Gu Jieruo 126
Next Page